Keywords: pseudovirus; Papillomavirus; Virion assembly; Pseudovirus;
مقالات ISI pseudovirus (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: pseudovirus; Ebola; Pseudovirus; Teicoplanin; High-throughput screening; Antiviral drug discovery;
Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors
Keywords: pseudovirus; 3D; 3-dimensional; BDBV; Bundibugyo virus; BSL; Biosafety Level; CLO; clomiphene; d.p.i.; day post-infection; DLIT; Diffuse Luminescence Imaging Tomography; EBOV; Ebola virus; GP; glycoprotein; h.p.i.; hour post-infection; i.p.; intraperitoneally; IC50; t
Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5
Keywords: pseudovirus; Coxsackievirus B5; Neutralizing antibody; Pseudovirus; Single round infection;
Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system
Keywords: pseudovirus; Chikungunya virus; Pseudovirus; Animal model; Bioluminescent imaging; DNA vaccine; pHIV-CHIKV-Fluc - p; pseudovirus; pHIV-CHIKV-Fluc - HIV; backbone; pHIV-CHIKV-Fluc - CHIKV; Chikungunya virus; pHIV-CHIKV-Fluc - Fluc; reporter gene; IV; intravenou
Quantitative and epitope-specific antigenicity analysis of the human papillomavirus 6 capsid protein in aqueous solution or when adsorbed on particulate adjuvants
Keywords: pseudovirus; HPV; human papillomavirus; VLP; recombinant virus-like particle; mAb; monoclonal antibody; PsV; pseudovirus; HRP; horseradish peroxidase; GFP; green fluorescent protein; HAI; hemagglutination inhibition; CSI; conformational sensitivity index; Human papill
A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3
Keywords: pseudovirus; Coxsackievirus B3; Pseudovirus; Neutralizing antibody; Seroprevalence
Effect of the maturation of neutralizing antibodies on human immunodeficiency virus (HIV) envelope evolution in HIV-infected subjects
Keywords: pseudovirus; HIV-1; Pseudovirus; Neutralizing antibody; Neutralization epitope;
Performance of a clonal-based HIV-1 tropism phenotypic assay
Keywords: pseudovirus; MVC; maraviroc; R5 viruses; viruses that use CCR5 co-receptor; HIV-1; human immunodeficiency virus 1; X4 viruses; viruses that use co-receptor CXCR4; X4R5/Dual-tropic; viruses that use both co-receptors CCR5 and CXCR4 co-receptors; D/M; mixed virus popula
Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV
Keywords: pseudovirus; JC polyomavirus; Progressive multifocal leukoencephalopathy; Pseudovirus; Natalizumab; Virus entry;
Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
Keywords: pseudovirus; Coxsackievirus A16; Pseudovirus; Luciferase; Neutralizing antibody assay;
Novel antivirals inhibit early steps in HPV infection
Keywords: pseudovirus; High throughput screen; Papillomavirus; Entry; Pseudovirus
The neutralization sensitivity of viruses representing human immunodeficiency virus type 1 variants of diverse subtypes from early in infection is dependent on producer cell, as well as characteristics of the specific antibody and envelope variant
Keywords: pseudovirus; Human immunodeficiency virus; Neutralizing antibodies; Producer cell; Pseudovirus
Optimization and proficiency testing of a pseudovirus-based assay for detection of HIV-1 neutralizing antibody in China
Keywords: pseudovirus; HIV; Neutralizing antibody assay; Proficiency test; TZM-bl; Pseudovirus;
Simple and convenient chromatography-based methods for purifying the pseudovirus of human papillomavirus type 58
Keywords: pseudovirus; Papillomavirus; Purification; HPV type 58; Pseudovirus; Heparin chromatography
G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates
Keywords: pseudovirus; Rabies virus; Monoclonal antibody; Neutralization; G glycoprotein; Pseudovirus
Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
Keywords: pseudovirus; Inhibitors of SARS-CoV entry; Antiviral; HTS; High-throughput screening; Dual envelope pseudovirion assay; Pseudovirus
Comparisons of the genetic and neutralization properties of HIV-1 subtype C and CRF07/08_BC env molecular clones isolated from infections in China
Keywords: pseudovirus; HIV-1; Subtype; Genetic; Neutralization; Pseudovirus
The design and validation of a novel phenotypic assay to determine HIV-1 coreceptor usage of clinical isolates
Keywords: pseudovirus; Chemokine receptor; Luciferase; Pseudovirus; Viral fitness; HIV; Viral tropism; Coreceptor usage; CCR5; CXCR4;
Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance
Keywords: pseudovirus; HIV-1; Pseudovirus; T20; Resistance;
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope
Keywords: pseudovirus; HIV-1; Vaccine; Neutralizing antibodies; V3 loop; gp120; Pseudovirus; Immunization
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
Keywords: pseudovirus; Human immunodeficiency virus type 1 (HIV-1); Antibodies; Neutralization assays; Pseudovirus; Vaccine immune assessment; Standardization;
Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays
Keywords: pseudovirus; HIV-1; Pseudovirus; Entry inhibitors; Antiviral activity
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models
Keywords: pseudovirus; HIV-1 neutralization; Cross-clade; Primary isolate; Pseudovirus; TZM-bl reporter cells;
Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope
Keywords: pseudovirus; HIV-1; Vaccine; Neutralizing antibodies; V3 loop; gp120; Pseudovirus; Immunization
Identification of synthetic vaccine candidates against SARS CoV infection
Keywords: pseudovirus; SARS CoV; Epitopes; Vaccine; Spike protein; Pseudovirus; Peptide
Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles
Keywords: pseudovirus; Human papillomavirus; HPV-11; HPV-16; Monoclonal antibodies; Fab fragments; Single-chain variable fragments (scFv); Virus neutralization; Viral epitopes; Vaccine; Pseudovirus; Virus like particles (VLPs)
Assembly of trans-encapsidated recombinant viral vectors engineered from Tobacco mosaic virus and Semliki Forest virus and their evaluation as immunogens
Keywords: pseudovirus; Tobacco mosaic virus; Reassembly; Semliki Forest virus; Pseudovirus; Antibody response; Cellular immune response; Alphavirus
Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
Keywords: pseudovirus; SARS-CoV; Pseudovirus; ACE2; Peptide; Entry inhibitor
HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensi
Keywords: pseudovirus; HIV-1; Vaccines; Neutralizing antibodies; Pseudovirus;